Please login to the form below

Not currently logged in
Email:
Password:

People, February, 2010

Recent high-profile moves in the pharmaceutical and healthcare industries
Mover of the month is Simon Jose who has been appointed President Designate of the Association of the British Pharmaceutical Industry (ABPI)

Mover of the month

 Simon Jose
 

Simon Jose, senior vice president and general manager of GlaxoSmithKline (GSK) UK Pharmaceuticals, has been named as President Designate of the Association of the British Pharmaceutical Industry (ABPI). Simon will take over from current ABPI President, Chris Brinsmead of AstraZeneca (UK), on April 28. He will serve for a one-year term, with the option for re-election for a further 12 months. Simon began his career with GSK in 1986 and since then held various sales and marketing roles of increasing seniority, both in Europe and North America, before assuming his current role in February 2008. Simon has been a member of the ABPI Board of Management since May 2008.

Interlace Global Group appoints three new members to its client services team to work for twin companies Wells Healthcare and Interlace Global Communications. Alan Nicolle (pictured - top) joins as client services director, Glenn Mursell as associate director and Sarah Vickery as assistant account manager. Alan has previously held senior marketing positions within global and European pharmaceutical companies. Glen has spent 18 years in pharmaceutical communications and Sarah has experience in the academic conference arena. The group has also strengthened its editorial team with the appointments of Laurence De-Netto (pictured - centre) as editorial team leader and Andrew Jobson (pictured - bottom) as medical writer. Laurence has 11 years experience in medical communications and is a strategic publications planning specialist. Andrew has a strong research background in anticancer drug discovery and development.  Alan NicolleLaurence De NettoAndrew Jobson

Amanda Stuart  

The Association of the British Pharmaceutical Industry (ABPI) has also promoted Alison Clough to commercial and communications director and appointed Amanda Stuart (pictured) as head of government affairs. Alison joined the ABPI in May from Innovex where she held a series of management roles, including running their UK business. Before Innovex, Alison spent 15 years at GlaxoSmithKline. She moves into the new role following the departure of David Lewis, director of corporate affairs, and David Fisher, commercial director. Amanda will spearhead the ABPI's work with politicians and those in government in both the UK and Europe. She was previously associate director at Insight Public Affairs, and is co-founder of Women in Communications, London.

Edelman has launched a specialist editorial team within its healthcare practice, and has promoted Ross Williams (pictured), who has worked with the company for five years, to associate director – editorial. The company has also appointed digital health expert, Justin Woodington, as a specialist resource working across Edelman's digital, health and medical education businesses (Spook Media, Edelman Healthcare and BioScience Communications). Previously, Justin spent five years at sanofi-aventis UK.


Ross Williams



Selwyn Learner, Gill Adams and Ed Bones


Selwyn Learner, Gill Adams and Ed Bones (pictured - left to right) have launched a new agency called Learner Adams Bones. Selwyn Learner was formerly creative director of Ogilvy Healthworld. Although he qualified as a pharmacist, his career has been as an advertising copywriter in agencies from WCRS to Paling Walters to Bates, (which became Ogilvy). Ed Bones spent a year at Paling Walters and the last four as creative director of Ogilvy Healthworld, following 16 years working on major consumer brands. Gill Adams is Learner Adams Bones' managing director. Combining consumer (Wrigley's) and pharma she was MD of Bates and, after a short departure, deputy MD of Ogilvy Healthworld.

 

MSD, the new global organisation formed from the merger of Merck & Co and Schering Plough, has announced the following UK human health leadership team appointments. Haseeb Ahmad is director of strategy, Keith Bousfield is director of primary care marketing, David Hewitt is director of consumer health, Jim Page is immunology business unit director, Kevin Peters is director of business operations, Chris Ponty is speciality business unit director, Kate Tillet is director of external affairs, Sally-Anne Tsangarides is hospital business unit director, Ilse van Roy is women's health business unit director, Craig Wallace is primary care sales director and Tim Williams is director of market access.

Joanne Shaw has been appointed as chair of NHS Direct to lead the Trust for the next four years. Joanne has been acting chair of NHS Direct since August 2008, prior to which she was a Trustee for the Long-term Conditions Alliance and chaired the not-for-profit company behind 'Ask About Medicines'.

Chamberlain Healthcare Public Relations, an inVentiv Health company, has appointed Mark John Cater as managing director of its London office. Mark was previously regional director, Europe, Middle East, Africa and India for Cohn & Wolfe, and chief executive officer of GCI UK prior to the company merging in 2008 with Cohn & Wolfe. He also spent six years in various leadership roles as partner and director at Ketchum where he was responsible for the company's worldwide healthcare practice.

Richard Nordstrom, who has been CEO of McCann Healthcare Worldwide since 2005, is leaving the company to take on new initiatives. His position is not being filled.  Instead, the company will be led by a newly created Office of the CEO, composed of four executives of the company. The four executives of the new Office of the CEO, who will have oversight responsibilities for McCann Healthcare Worldwide in addition to ongoing responsibilities for the companies they lead, are: Marci Piasecki, CEO of Torre Lazur Healthcare Group; Maureen Regan, managing partner of RCW Group; David Bachmann, CFO of McCann Healthcare Worldwide; John Cahill, President, McCann Healthcare EMEA and Asia Pacific and of the worldwide medical communications groups. John Cahill will be the chairman of the Office of the CEO.

Five people have taken key roles following the re-organisation of Huntsworth Health Europe. ApotheCom Europe – the medical communications company - will report to David Dunn, global CEO of ApotheCom; Jon Clark will manage Nitrogen Chiswick – the brand communications business - and nitrogen interactive - the digital agency - and nitrogen Marlow will be managed by Cory Inglis. Mike Brown, previously COO North America has been appointed global COO of Huntsworth Health, and Anthea Davies has joined the team from Publicis as operations director for Huntsworth Health Europe.

Eurocom has announced the appointment of Rachel Underwood as creative copywriter. Formerly of Huntsworth Health, Rachel brings over 10 years' scientific and marketing communications experience to the role, working with both local and global brands.

Porter Novelli has appointed Sally Ward as partner and managing director of its operations in the UK. She was previously founder and director of Plum Consulting, an executive search, talent management and senior-level coaching and mentoring firm. Prior to this she spent five years with Weber Shandwick UK, and before that, seven years with Porter Novelli (known then as Countrywide Porter Novelli) as a portfolio director and later as the agency's UK development director.

Fleishman Hillard has appointed Richard Marsh as director and partner in regional healthcare. Based in Fleishman-Hillard's offices in London, Richard will be operating across the UK, Middle East and Africa region. Richard is a former special adviser to two Secretaries of State for Health in the last Conservative Government, as well as a special adviser with experience of two other government departments and a former speechwriter for Prime Ministers Margaret Thatcher and John Major. This is also his second spell at Fleishman-Hillard, having previously led the company's UK healthcare public affairs team. Since 2002, Richard has been the director of external affairs and market access for the UK pharmaceuticals business of Bristol-Myers Squibb (BMS).

Chris Marks, who has been with The MSI Consultancy – part of the Cello Group – for ten years, has been appointed brand services principal of the firm's newly created specialist brand services arm. In addition to his decade at MSI, Chris has a wealth of OTC and fast moving consumer goods (fmcg) brand experience.

 

Paul Jewsbury



Obituary - Paul Jewsbury
In December 2009, Paul Jewsbury sadly lost his long and hard fought battle against a reoccurring brain tumour, leaving behind his beloved wife Jenny and their two girls. Paul, or PJ as his colleagues knew him, started his career in the industry in 1987 at Winthrop Laboratories, as a medical representative. He also held various positions within medical education and advertising agencies including Medicus, Lane, Earl & Cox and Pan Communications where he managed the Cephalon account. Paul eventually joined Cephalon's marketing team taking responsibility for their pain portfolio and remained there for the next six years of his career. Paul was a realist, yet very mischievous and always had an optimistic view on life and work. He respected and valued the contribution his colleagues and the agencies who worked with him made and always had a "hello chuck" for everyone. If you would like to donate to the Brain Tumour Research Campaign in memory of Paul please go to:
www.justgiving.com/Jenny-Jewsbury


 

Related links

FAQ: How do I get my move listed

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics